Back
Arvinas Vs. West Pharmaceutical Services Industry Stock Comparison
Sell
41
ARVN
Arvinas
Last Price:
25.41
Seasonality Move:
12.72%
Sell
45
WST
West Pharmaceutical Services
Last Price:
296.66
Seasonality Move:
1.15%
Sell
41
Arvinas (ARVN)
is a Sell
Is Arvinas a Buy, Sell or Hold?
- The current Arvinas [ARVN] share price is $25.05. The Score for ARVN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ARVN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
West Pharmaceutical Services (WST)
is a Sell
Is West Pharmaceutical Services a Buy, Sell or Hold?
- The current West Pharmaceutical Services [WST] share price is $300.67. The Score for WST is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- WST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARVN Stock Price Chart
WST Stock Price Chart
What is West Pharmaceutical Services's stock price today?
-
The West Pharmaceutical Services share price today is $300.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WST is experiencing slight buying pressure.
ARVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 46.9 | Sell |
| Chaikin Money Flow: | 23043 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.5 - 25.88) | Sell |
| Bollinger Bands (100): | (24.78 - 31.64) | Sell |
WST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.86 | Sell |
| Relative Strength Index (14 RSI): | 48.12 | Sell |
| Chaikin Money Flow: | 178657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (294.5 - 306.62) | Buy |
| Bollinger Bands (100): | (299.2 - 347.82) | Sell |
ARVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.94 | Buy |
| 20-day SMA: | 25.33 | Sell |
| 50-day SMA: | 26.47 | Sell |
| 200-day SMA: | 34.18 | Sell |
| 8-day EMA: | 25.04 | Buy |
| 20-day EMA: | 25.32 | Sell |
| 50-day EMA: | 26.36 | Sell |
| 200-day EMA: | 30.31 | Sell |
WST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 301.29 | Sell |
| 20-day SMA: | 302.77 | Sell |
| 50-day SMA: | 305.45 | Sell |
| 200-day SMA: | 345.77 | Sell |
| 8-day EMA: | 301.53 | Sell |
| 20-day EMA: | 302.14 | Sell |
| 50-day EMA: | 307.89 | Sell |
| 200-day EMA: | 335.07 | Sell |
Arvinas Earnings Growth & ARVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.65 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.
West Pharmaceutical Services Earnings Growth & WST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, an increase next quarter of $0.29 per share, a decrease this year of $1.61 per share, and an increase next year of $1.26 per share.
Arvinas Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
West Pharmaceutical Services Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||